Suchergebnisse - "Memory Disorders drug therapy"
-
1
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Mol Psychiatry
Schlagwörter: Corticotropin-releasing hormone, 0301 basic medicine, Signaling pathways, Corticotropin-Releasing Hormone, Neurotrophic factor, Memory, Short-term, Stress, Hippocampus, Receptors, Corticotropin-Releasing Hormone, Dendritic spines, Article, Mice, 03 medical and health sciences, physical trauma, Psychology, Animals, Humans, Nerve growth factors, 10. No inequality, Neurotrophic functions, Neurons, Memory Disorders, 0303 health sciences, Depression, Working memory, Neurosciences, Receptor antagonist, Delirium, Syndrome, Neuroscience, Humans [MeSH], Syndrome [MeSH], Delirium [MeSH], Memory Disorders/etiology [MeSH], Animals [MeSH], Corticotropin-Releasing Hormone [MeSH], Memory Disorders/drug therapy [MeSH], Mice [MeSH], Neurons [MeSH], Receptors, Corticotropin-Releasing Hormone [MeSH], older patients, 3. Good health, Risk factors, Nuklearfaktor Kappa B, Kurzzeitgedächtnis, Corticoliberin, Stress, Psychological, Risikofaktor
Dateibeschreibung: application/pdf
Zugangs-URL: https://www.nature.com/articles/s41380-020-0659-y.pdf
https://pubmed.ncbi.nlm.nih.gov/32051550
https://www.nature.com/articles/s41380-020-0659-y
https://www.nature.com/articles/s41380-020-0659-y.pdf
https://oparu.uni-ulm.de/xmlui/handle/123456789/26016
https://ulir.ul.ie/handle/10344/8624
https://ulir.ul.ie/bitstream/10344/8624/2/Grabrucker_2019_CRHRI.pdf
https://www.ncbi.nlm.nih.gov/pubmed/32051550
https://repository.publisso.de/resource/frl:6471330 -
2
Autoren: et al.
Quelle: Neuropharmacology. 135:48-62
Schlagwörter: 18fluorodeoxyglucose, Male, 0301 basic medicine, oral galactose, intracerebroventricular, Administration, Oral, sporadic Alzheimer's disease, streptozotocin, Glucagon-Like Peptide-1 Receptor, Streptozocin, Galactose/therapeutic use, memory, Galactose/administration & dosage, 03 medical and health sciences, oral galactose: streptozotocin, intracerebroventricular, sporadic Alzheimer's disease, memory, glucagon-like peptide-1, 0302 clinical medicine, Alzheimer Disease, Glucagon-Like Peptide 1, Glucagon-Like Peptide 1/blood, Brain/metabolism, Glucose/metabolism, Animals, Memory Disorders, Alzheimer Disease/drug therapy, Memory Disorders/drug therapy, Brain, Galactose, Glucagon-Like Peptide-1 Receptor/biosynthesis, Rats, 3. Good health, Glucose
Dateibeschreibung: application/pdf
-
3
Autoren: et al.
Quelle: Anatomy and Cell Biology Publications
Schlagwörter: Male, 0301 basic medicine, Ovariectomy, Vesicular Acetylcholine Transport Proteins, RNA, Messenger/metabolism, Acetylcholine, Estradiol, Object recognition memory, Estrogen receptors, Mice, Transgenic, Hippocampus/drug effects/metabolism, Hippocampus, Recognition, Psychology/drug effects/physiology, Cell and Developmental Biology, 03 medical and health sciences, Sex Factors, 0302 clinical medicine, Animals, Nootropic Agents/pharmacology, RNA, Messenger, Nootropic Agents, Memory Disorders, Estrogens/pharmacology, Estrogens, Recognition, Psychology, Memory, Short-Term/drug effects/physiology, Life sciences, Vesicular Acetylcholine Transport Proteins/deficiency/genetics, Estradiol/pharmacology, Memory, Short-Term, Receptors, Estrogen, Acetylcholine/metabolism, Sciences du vivant, Memory Disorders/drug therapy/metabolism, Female, Anatomy, Receptors, Estrogen/metabolism
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/29447857
https://www.sciencedirect.com/science/article/pii/S0361923017304148
https://ir.lib.uwo.ca/anatomypub/259/
https://www.sciencedirect.com/science/article/abs/pii/S0361923017304148#!
https://www.ncbi.nlm.nih.gov/pubmed/29447857
https://ir.lib.uwo.ca/anatomypub/259 -
4
Autoren: et al.
Quelle: Journal of Pharmacological Sciences, Vol 136, Iss 3, Pp 149-154 (2018)
Schlagwörter: 0301 basic medicine, ß-Amyloid, hippocampus, Chinese Herbal, Wistar, Acetylcholine/*metabolism, Amyloid beta-Peptides/*toxicity, Animals, Drugs, Chinese Herbal/administration & dosage/*pharmacology, Female, Hippocampus/*metabolism, Maze Learning/drug effects, Memory Disorders/*drug therapy/*etiology/psychology, Ovariectomy/*adverse effects, Rats, Wistar, Spatial Memory/*drug effects, Wistar rat, Hippocampus, radial arm maze test, rat, animal, Spatial Memory, 0303 health sciences, drug effect, Drugs, memory disorder, spatial memory, donepezil, 3. Good health, female, ovariectomy, β-Amyloid, dorsal hippocampus, Ovariectomy, animal experiment, RM1-950, psychology, Article, 03 medical and health sciences, Memory, drug mechanism, tokishakuyaku san, controlled study, maze test, Maze Learning, Tokishakuyakusan, Memory Disorders, nonhuman, Amyloid beta-Peptides, amyloid beta protein[1-42], animal model, acetylcholine, Acetylcholine, Rats, toki-shakuyaku-san, herbaceous agent, amyloid beta protein, Therapeutics. Pharmacology, metabolism, Drugs, Chinese Herbal
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/29478713
https://doaj.org/article/7bd873b4047640b1b927fab2c45a2b5b
https://core.ac.uk/display/153599206
https://kyushu-u.pure.elsevier.com/ja/publications/tokishakuyakusan-ameliorates-spatial-memory -deficits-induced-by-o
https://www.ncbi.nlm.nih.gov/pubmed/29478713
https://pubmed.ncbi.nlm.nih.gov/29478713/
https://www.sciencedirect.com/science/article/abs/pii/S1347861318300173
https://www.sciencedirect.com/science/article/pii/S1347861318300173
https://hdl.handle.net/11499/10839
https://doi.org/10.1016/j.jphs.2018.01.005
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/10839 -
5
Weitere Verfasser: et al.
Schlagwörter: AMP-Activated Protein Kinases / metabolism, Adiponectin / deficiency, Alzheimer Disease / drug therapy, Alzheimer Disease / metabolism, Alzheimer Disease / psychology, Amyloid beta-Peptides / genetics, Animals, Cell Line, Tumor, Drug Evaluation, Preclinical, Humans, Insulin Resistance, Male, Maze Learning, Memory Disorders / drug therapy, Memory Disorders / etiology, Memory Disorders / prevention & control, Mice, Inbred C57BL, Knockout, Transgenic, Neurons / drug effects, Neuroprotective Agents / pharmacology, Neuroprotective Agents / therapeutic use, Presenilin-1 / genetics, RNA Interference, RNA, Small Interfering / genetics, Receptors
Relation: MOLECULAR NEURODEGENERATION; J02263; https://ir.ymlib.yonsei.ac.kr/handle/22282913/186994; T202104911
-
6
Autoren:
Quelle: Ageing research reviews. 5(3)
Schlagwörter: Aging: physiology, Animals, Brain: drug effects, physiology, Humans, Long-Term Potentiation: drug effects, Memory Disorders: drug therapy, physiopathology, Neuronal Plasticity: drug effects, Nootropic Agents: pharmacology, therapeutic use
Dateibeschreibung: application/pdf
-
7
Autoren: et al.
Quelle: Life Sciences. 136:108-119
Schlagwörter: M30 compound, Male, 0301 basic medicine, HLA20 compound, Memory, Long-Term, Alzheimer Disease/chemically induced, Drug Evaluation, Preclinical, Iron Chelating Agents/therapeutic use, Iron Chelating Agents, Insulin degrading enzyme, Piperazines, Streptozocin, 03 medical and health sciences, 0302 clinical medicine, Alzheimer Disease/psychology, Memory, Alzheimer Disease, Tau protein, Animals, Alzheimer's disease, Streptozotocin, Piperazines/pharmacology, Rats, Wistar, Hydroxyquinolines/therapeutic use, Memory Disorders, Alzheimer Disease/drug therapy, Memory Disorders/drug therapy, Hydroxyquinolines/pharmacology, Memory, Long-Term/drug effects, Piperazines/therapeutic use, Iron Chelating Agents/pharmacology, 3. Good health, Disease Models, Animal, Neuroprotective Agents, Neuroprotective Agents/therapeutic use, Hydroxyquinolines, Neuroprotective Agents/pharmacology
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/26159898
https://www.sciencedirect.com/science/article/pii/S0024320515003501
https://www.ncbi.nlm.nih.gov/pubmed/26159898
https://pubmed.ncbi.nlm.nih.gov/26159898/
https://europepmc.org/article/MED/26159898
https://core.ac.uk/display/148765207
https://www.bib.irb.hr/810996 -
8
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Neuropharmacology. 85:178-189
Schlagwörter: Male, 0301 basic medicine, Piperidines/pharmacology, Scopolamine, Anxiety, Avoidance Learning/drug effects, scopolamine, Serotonin 5-HT4 Receptor Agonists/pharmacology, Random Allocation, Serotonin 5-HT4 Receptor Agonists, 03 medical and health sciences, 0302 clinical medicine, Piperidines, Receptors, Serotonin, 5-HT4/metabolism, Avoidance Learning, Animals, Nootropic Agents/pharmacology, Maze Learning, Nootropic Agents, Benzofurans, Memory Disorders, Memory Disorders/drug therapy, Dose-Response Relationship, Drug, Galantamine, Anxiety/drug therapy, Fear, Benzofurans/pharmacology, Mice, Inbred C57BL, Disease Models, Animal, Fear/drug effects, Maze Learning/drug effects, Receptors, Serotonin, 5-HT4, Galantamine/pharmacology
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/24863046
https://www.ncbi.nlm.nih.gov/pubmed/24863046
https://europepmc.org/article/MED/24863046
https://core.ac.uk/display/34605272
https://researchportal.vub.be/en/publications/ssp-002392-a-new-5-ht4-receptor-agonist-dose-dependently-reverses
https://www.sciencedirect.com/science/article/pii/S0028390814001804
https://biblio.vub.ac.be/vubir/ssp002392-a-new-5ht4-receptor-agonist-dosedependently-reverses-scopolamineinduced-learning-and-memory -impairments-in-c57bl6-mice(4d8da528-9399-4ae7-91ac-a0dae69ed805).html -
9
Autoren: et al.
Quelle: Molecular Psychiatry. 19:588-598
Schlagwörter: Male, 0301 basic medicine, Pyramidal Cells - physiopathology, Memory Disorders - physiopathology, Synaptic Transmission, Recognition (Psychology) - drug effects, Rats, Sprague-Dawley, Cognition, 0302 clinical medicine, Glutamate - metabolism, Receptors, Estrogens - pharmacology, Prefrontal Cortex - physiopathology, Sex Characteristics, Estradiol, Aromatase Inhibitors, Pyramidal Cells, Psychological - drug therapy, Receptors, Estrogen, Receptors, Glutamate, Synaptic Transmission - physiology, Female, Cognition - physiology, Estrogen - metabolism, Cognition - drug effects, Glutamic Acid, Prefrontal Cortex, Synaptic Transmission - drug effects, Stress, Aromatase - metabolism, 03 medical and health sciences, Aromatase, Animals, RNA, Messenger, Prefrontal Cortex - drug effects, Memory Disorders, Psychological - physiopathology, Aromatase Inhibitors - pharmacology, Glutamic Acid - metabolism, Pyramidal Cells - drug effects, Messenger - metabolism, Estrogens, Recognition, Psychology, Estradiol - pharmacology, Rats, Memory Disorders - drug therapy, RNA, Sprague-Dawley, Recognition (Psychology) - physiology, Stress, Psychological
Zugangs-URL: https://www.nature.com/articles/mp201383.pdf
https://pubmed.ncbi.nlm.nih.gov/23835908
http://www.acsu.buffalo.edu/~zhenyan/MPs-female+stress.pdf
https://pubmed.ncbi.nlm.nih.gov/23835908/
https://www.nature.com/articles/mp201383.pdf
https://www.ncbi.nlm.nih.gov/pubmed/23835908
https://www.nature.com/articles/mp201383
https://www.acsu.buffalo.edu/~zhenyan/MPs-female+stress.pdf -
10
Autoren: Walesiuk, Anna
Quelle: Fitoterapia. 81:25-29
-
11
Autoren: Walesiuk, Anna
Quelle: Phytomedicine. 16(1):40-46
Schlagwörter: Male, Memory disorders - drug therapy, Maze learning - drug effects, Plant extracts - pharmacology, Memory disorders - prevention & control, Wistar, Ginkgo biloba, psychological - complications, Plant extracts - therapeutic use, Restraint, Stress, Rats, Memory disorders - etiology, Animals, Analysis of variance, Corticosterone, physical, Phytotherapy
-
12
Autoren: et al.
Weitere Verfasser: et al.
Quelle: ISSN: 1932-6203.
Schlagwörter: MESH: Aging/drug effects, MESH: Alzheimer Disease/complications, MESH: Sleep Deprivation/drug therapy, MESH: Sleep Deprivation/physiopathology, MESH: Spatial Memory/drug effects, MESH: Alzheimer Disease/drug therapy, MESH: Alzheimer Disease/physiopathology, MESH: Animals, MESH: Cheirogaleidae, MESH: Disease Models, Animal, MESH: Donepezil, MESH: Indans/pharmacology, MESH: Male, MESH: Memantine/pharmacology, MESH: Memory Disorders/drug therapy, MESH: Memory Disorders/etiology, MESH: Memory Disorders/physiopathology, MESH: Piperidines/pharmacology, MESH: Sleep Deprivation/complications, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Relation: info:eu-repo/semantics/altIdentifier/pmid/28922421; PUBMED: 28922421; PUBMEDCENTRAL: PMC5602634
-
13
Autoren: Walesiuk, Anna
Quelle: Pharmacological Research. 53(2):123-128
Schlagwörter: Memory disorders - drug therapy, Behavior, Zwierzęta, Miłorząb dwuklapowy, Mental recall - drug effects, Szczury, Kortykosteron - farmakologia, Ginkgo biloba, psychological - complications, Przypominanie sobie - wpływ środków chemicznych, Zaburzenia pamięci - farmakoterapia, Plant extracts - therapeutic use, Stress, Rats, Corticosterone - pharmacology, Pamięć - wpływ środków chemicznych, animal - drug effects, Memory - drug effects, Uczenie się unikania - wpływ środków chemicznych, Avoidance learning - drug effects, Stres psychologiczny - powikłania, Zachowanie zwierząt - wpływ środków chemicznych, Animals, Wyciągi roślinne - stosowanie lecznicze
-
14
Autoren: Walesiuk, Anna
Quelle: Pharmacological Reports. 57(2):176-187
Schlagwörter: Memory disorders - drug therapy, Behavior, Zwierzęta, Miłorząb dwuklapowy, Plant extracts - pharmacology, Szczury, Ginkgo biloba, psychological - complications, Zaburzenia pamięci - farmakoterapia, Stress, Rats, animal - drug effects, Stres psychologiczny - powikłania, Wyciągi roślinne - farmakologia, Zachowanie zwierząt - wpływ środków chemicznych, Aktywność fizyczna - wpływ środków chemicznych, Motor activity - drug effects, Animals
-
15
Autoren: et al.
Quelle: Life Sciences. 75:1967-1978
Schlagwörter: Male, 0301 basic medicine, hippocampus, Wistar, Apoptosis, nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase, Brain Ischemia, interleukin 1beta converting enzyme, caspase 3, rat, enzyme inhibition, 0303 health sciences, Caspase 3, drug effect, Caspase 1, apoptosis, article, 3 aminobenzamide, memory disorder, spatial memory, Caspase Inhibitors, Caspase-3, Caspase-1, Caspases, immunohistochemistry, Benzamides, Drug, Poly(ADP-ribose) Polymerases, Oligopeptides, interleukin 1beta converting enzyme inhibitor, animal experiment, blood vessel occlusion, Poly(ADP-ribose) Polymerase Inhibitors, PARP, animal tissue, Dose-Response Relationship, 03 medical and health sciences, Animals, Apoptosis/*drug effects, Benzamides/*pharmacology/therapeutic use, Brain Ischemia/physiopathology, Caspase 1/metabolism, Dose-Response Relationship, Drug, In Situ Nick-End Labeling, Memory Disorders/*drug therapy, Oligopeptides/*pharmacology/therapeutic use, Rats, Rats, Wistar, Spatial memory, male, controlled study, maze test, caspase 3 inhibitor, Repeated cerebral ischemia/reperfusion, Memory Disorders, nonhuman, animal model, brain ischemia, nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/15306164
https://www.sciencedirect.com/science/article/pii/S0024320504005430
https://www.sciencedirect.com/science/article/pii/S0024320504005430#!
https://kyushu-u.pure.elsevier.com/en/publications/inhibition-of-poly-adp-ribose-polymerase-and-caspase-3-but-not-ca
https://www.ncbi.nlm.nih.gov/pubmed/15306164
http://www.sciencedirect.com/science/article/pii/S0024320504005430
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/5048 -
16
Weitere Verfasser: et al.
Schlagwörter: Alzheimer Disease/drug therapy, Amyloid beta-Peptides/metabolism, Animals, Apoptosis/drug effects, Cell Survival/drug effects, Chalcone/analogs & derivatives, Chalcones/pharmacology, Chalcones/therapeutic use, Chalcones/toxicity, Cognition Disorders/drug therapy, Lethal Dose 50, Male, Maze Learning, Memory Disorders/drug therapy, Mice, Inbred ICR, Neuroprotective Agents/pharmacology, Neuroprotective Agents/therapeutic use, Oxidative Stress/drug effects, Oximes/pharmacology, Oximes/therapeutic use, Oximes/toxicity, PC12 Cells, Random Allocation, Rats
Relation: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; J01132; https://ir.ymlib.yonsei.ac.kr/handle/22282913/90494; T201202387; 32801
-
17
Autoren: et al.
Schlagwörter: Actins/metabolism, Animals, Dendritic Spines/drug effects, Disease Models, Animal, Eukaryotic Initiation Factor-4E/antagonists & inhibitors, Eukaryotic Initiation Factor-4E/genetics, Eukaryotic Initiation Factor-4E/metabolism, Eukaryotic Initiation Factor-4G/antagonists & inhibitors, Eukaryotic Initiation Factor-4G/genetics, Eukaryotic Initiation Factor-4G/metabolism, Fragile X Mental Retardation Protein/genetics, Fragile X Mental Retardation Protein/metabolism, Fragile X Syndrome/drug therapy, Fragile X Syndrome/metabolism, Hippocampus/drug effects, Hippocampus/physiopathology, Hydrazones/pharmacology, Hydrazones/therapeutic use, Male, Memory Disorders/drug therapy, Mice, Inbred C57BL, Nerve Tissue Proteins/genetics, Nerve Tissue Proteins/metabolism, Thiazoles/pharmacology, Thiazoles/therapeutic use
Relation: Science Signaling; https://iris.unil.ch/handle/iris/131923; serval:BIB_60DD9AD64B2D; 000414564100001
-
18
Autoren: et al.
Quelle: Neurobiology of learning and memory 140, 11-16 (2017). doi:10.1016/j.nlm.2017.02.006
Schlagwörter: info:eu-repo/classification/ddc/570, Animals, Cognition: drug effects, Disease Models, Animal, Down Syndrome: drug therapy, Down Syndrome: genetics, Flumazenil: pharmacology, Flumazenil: therapeutic use, GABA Modulators: pharmacology, GABA Modulators: therapeutic use, Male, Memory Disorders: drug therapy, Memory, Long-Term: drug effects, Mice, GABA Modulators, Flumazenil
Geographisches Schlagwort: DE
Relation: info:eu-repo/semantics/altIdentifier/issn/1095-9564; info:eu-repo/semantics/altIdentifier/issn/1074-7427; info:eu-repo/semantics/altIdentifier/pmid/pmid:28215510; https://pub.dzne.de/record/139181
-
19
Autoren: et al.
Quelle: Neurobiology of disease 95, 22-34 (2016). doi:10.1016/j.nbd.2015.09.001
Schlagwörter: info:eu-repo/classification/ddc/570, Animals, Brain-Derived Neurotrophic Factor: metabolism, Cognition Disorders: metabolism, Dinoprostone: metabolism, Disease Models, Animal, Hippocampus: metabolism, Huntington Disease: metabolism, Huntington Disease: physiopathology, Memory: physiology, Memory Disorders: drug therapy, Memory Disorders: physiopathology, Mice, Transgenic, Neuronal Plasticity: physiology, Receptors, Prostaglandin E, EP2 Subtype: metabolism, Brain-Derived Neurotrophic Factor, EP2 Subtype, Dinoprostone
Geographisches Schlagwort: DE
Relation: info:eu-repo/semantics/altIdentifier/issn/0969-9961; info:eu-repo/semantics/altIdentifier/pmid/pmid:26369879; info:eu-repo/semantics/altIdentifier/issn/1095-953X; https://pub.dzne.de/record/138769
-
20
Autoren: et al.
Quelle: Psychiatry Research. 178(1):1-9
Schlagwörter: Facial Expression, Recognition, Memory Disorders/drug therapy, Humans, PubMed/statistics & numerical data, Schizophrenia/complications, Antipsychotic Agents/therapeutic use, Psychology/drug effects
Full Text Finder
Nájsť tento článok vo Web of Science